KIR2DS4 Antibody (Center) Blocking Peptide

Produktübersicht

• Artikelname: KIR2DS4 Antibody (Center) Blocking Peptide
• Artikelnummer: ABT-BP8581C
• Hersteller Artikelnummer: BP8581c
• Alternativnummer: ABT-BP8581C-500UG
• Hersteller: Abcepta
• Kategorie: Proteine/Peptide
• Alternative Synonym: Killer cell immunoglobulin-like receptor 2DS4, CD158 antigen-like family member I, MHC class I NK cell receptor, Natural killer-associated transcript 8, NKAT-8, P58 natural killer cell receptor clones CL-39/CL-17, p58 NK receptor CL-39/CL-17, CD158i, KIR2DS4, CD158I, KKA3, NKAT8

Produktbeschreibung

KIR2DS4 is the receptor on natural killer (NK) cells for HLA-C alleles. Does not inhibit the activity of NK cells.

Produkteigenschaften

• NCBI: 3809
• UniProt: P43632
• Formulierung: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
• Target-Kategorie: The synthetic peptide sequence used to generate the antibody AP8581c was selected from the Center region of human KIR2DS4. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.